Mangal Texofab Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 6.94%
- Profit Growth 39.15%
- Ebitda 21.25%
- Net Worth 33.25%
- Total Assets 3.25%
About Mangal Texofab
Mangal Texofab Private Limited (MTPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 November 2004 and has a history of 20 years and three months. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nemi Gupta and Hem Gupta serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U18101RJ2004PTC019886
- Company No.
019886
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2004
- Date of AGM
05 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Mangal Texofab?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nemi Gupta ![]() | Director | 11-Nov-2004 | Current |
Hem Gupta ![]() | Director | 11-Nov-2004 | Current |
Financial Performance of Mangal Texofab.
Mangal Texofab Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.94% increase. The company also saw a substantial improvement in profitability, with a 39.15% increase in profit. The company's net worth Soared by an impressive increase of 33.25%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Mangal Texofab?
In 2018, Mangal Texofab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Mangal Texofab?
Unlock and access historical data on people associated with Mangal Texofab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Mangal Texofab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mangal Texofab's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.